1. Home
  2. Southern Africa
  3. Zimbabwe

HIV/AIDS drug scheme planned for end of 2003

Zimbabwe has announced plans for a national HIV/AIDS drug programme for the end of 2003, local newspaper The Herald reported on Wednesday. The Minister of Health and Child Welfare, Dr David Parirenyatwa, said he was optimistic that the decreasing costs of antiretrovirals could result in many people benefiting from the programme. The cost of HIV/AIDS treatment in most countries surveyed in 2002 by the World Health Organisation (WHO) had dropped to around US $300 per patient a year, down from US $10,000 a decade ago. "Combined with increasing financial support from organisations and partners such as the Global AIDS Fund," Parirenyatwa said, "these are positive moves to increasing access to care and treatment for people living with HIV/AIDS." He said the government plans for increased access to HIV/AIDS care and treatment would also focus on home-based care as "health facilities are failing to cope with the high demand".

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join